Stephan Chalon

2.6k total citations
50 papers, 1.5k citations indexed

About

Stephan Chalon is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Stephan Chalon has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Public Health, Environmental and Occupational Health, 12 papers in Pharmacology and 11 papers in Computational Theory and Mathematics. Recurrent topics in Stephan Chalon's work include Malaria Research and Control (26 papers), Computational Drug Discovery Methods (11 papers) and Drug-Induced Hepatotoxicity and Protection (10 papers). Stephan Chalon is often cited by papers focused on Malaria Research and Control (26 papers), Computational Drug Discovery Methods (11 papers) and Drug-Induced Hepatotoxicity and Protection (10 papers). Stephan Chalon collaborates with scholars based in Switzerland, United States and Australia. Stephan Chalon's co-authors include Jean-Pierre Boissel, Michel Cucherat, Philippe Lechat, Milton Packer, James McCarthy, Jörg J. Möhrle, Cathie Leister, Daryl Sonnichsen, Richat Abbas and Terrence F. Blaschke and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Clinical Infectious Diseases.

In The Last Decade

Stephan Chalon

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan Chalon Switzerland 22 493 437 198 130 128 50 1.5k
Anil Verma India 26 1.8k 3.7× 134 0.3× 282 1.4× 20 0.2× 162 1.3× 80 2.7k
Manuel Román Spain 25 110 0.2× 115 0.3× 228 1.2× 71 0.5× 158 1.2× 116 1.9k
Yvette McNeil Australia 21 99 0.2× 381 0.9× 259 1.3× 20 0.2× 111 0.9× 30 1.3k
Milou‐Daniel Drici France 21 666 1.4× 67 0.2× 534 2.7× 31 0.2× 264 2.1× 73 1.6k
A.A. Ajayi Nigeria 21 410 0.8× 82 0.2× 161 0.8× 16 0.1× 62 0.5× 69 1.2k
Daniel F. Carr United Kingdom 24 57 0.1× 63 0.1× 252 1.3× 61 0.5× 128 1.0× 67 1.5k
Dolores Ochoa Spain 25 100 0.2× 99 0.2× 207 1.0× 74 0.6× 60 0.5× 98 1.6k
Armel Stockis Belgium 32 126 0.3× 60 0.1× 242 1.2× 32 0.2× 180 1.4× 97 2.9k
Guillermo Di Girolamo Argentina 22 241 0.5× 312 0.7× 237 1.2× 17 0.1× 74 0.6× 107 1.3k
Christabelle J. Darcy Australia 10 93 0.2× 318 0.7× 131 0.7× 18 0.1× 56 0.4× 11 801

Countries citing papers authored by Stephan Chalon

Since Specialization
Citations

This map shows the geographic impact of Stephan Chalon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Chalon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Chalon more than expected).

Fields of papers citing papers by Stephan Chalon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Chalon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Chalon. The network helps show where Stephan Chalon may publish in the future.

Co-authorship network of co-authors of Stephan Chalon

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Chalon. A scholar is included among the top collaborators of Stephan Chalon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Chalon. Stephan Chalon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuemmerle, Andrea, Raman Sharma, Anthony Cahn, et al.. (2025). First‐in‐human safety, tolerability, pharmacokinetics and pilot food‐effect study of the candidate antimalarial compound MMV367. British Journal of Clinical Pharmacology. 91(6). 1821–1833. 1 indexed citations
2.
Barber, Bridget E., Adam J. Potter, Stacey Llewellyn, et al.. (2024). Characterising the blood-stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparum. International Journal of Antimicrobial Agents. 64(1). 107196–107196. 4 indexed citations
3.
Kuemmerle, Andrea, et al.. (2024). Randomized, placebo‐controlled, double‐blind phase I trial of co‐administered pyronaridine and piperaquine in healthy adults of sub‐Saharan origin. Clinical and Translational Science. 17(4). e13738–e13738. 2 indexed citations
4.
Woolley, Stephen, Matthew J. Grigg, Louise Marquart, et al.. (2024). Longitudinal changes in iron homeostasis in human experimental and clinical malaria. EBioMedicine. 105. 105189–105189. 4 indexed citations
5.
6.
Täubel, Jörg, et al.. (2021). Concentration‐QT modelling of the novel DHFR inhibitor P218 in healthy male volunteers. British Journal of Clinical Pharmacology. 88(1). 128–137. 4 indexed citations
7.
Woolley, Stephen, Maria Rebelo, Stacey Llewellyn, et al.. (2021). Development and evaluation of a new Plasmodium falciparum 3D7 blood stage malaria cell bank for use in malaria volunteer infection studies. Malaria Journal. 20(1). 93–93. 7 indexed citations
8.
Marquart, Louise, Lachlan Webb, Laura Cascales, et al.. (2020). Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia. PLoS Medicine. 17(8). e1003203–e1003203. 19 indexed citations
9.
Collins, Katharine A., Claire Wang, Matthew Adams, et al.. (2020). A Plasmodium vivax experimental human infection model for evaluating efficacy of interventions. Journal of Clinical Investigation. 130(6). 2920–2927. 21 indexed citations
10.
Duparc, Stephan, et al.. (2020). Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review. Malaria Journal. 19(1). 111–111. 9 indexed citations
11.
Collins, Katharine A., Claire Wang, Matthew Adams, et al.. (2018). A controlled human malaria infection model enabling evaluation of transmission-blocking interventions. Journal of Clinical Investigation. 128(4). 1551–1562. 79 indexed citations
12.
McCarthy, James, Julie Lotharius, Thomas Rückle, et al.. (2017). Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study. The Lancet Infectious Diseases. 17(6). 626–635. 82 indexed citations
13.
Korth‐Bradley, Joan, Virginia Parks, Frank Wagner, et al.. (2013). Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects. Clinical Pharmacology in Drug Development. 3(2). 151–157. 15 indexed citations
14.
Abbas, Richat, et al.. (2012). Evaluation of the pharmacokinetics and safety of bosutinib in patients with chronic hepatic impairment and matched healthy subjects. Cancer Chemotherapy and Pharmacology. 71(1). 123–132. 33 indexed citations
15.
Chalon, Stephan, et al.. (2004). Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. Psychopharmacology. 177(4). 357–365. 35 indexed citations
16.
Chalon, Stephan, et al.. (2003). Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: A Double-Blind, Controlled Study. Neuropsychopharmacology. 28(9). 1685–1693. 82 indexed citations
17.
Chalon, Stephan, et al.. (1999). Role of nitric oxide in isoprenaline and sodium nitroprusside‐induced relaxation in human hand veins. British Journal of Clinical Pharmacology. 47(1). 91–98. 8 indexed citations
18.
Tangphao, Oranee, et al.. (1999). Heparin-induced vasodilation in human hand veins*. Clinical Pharmacology & Therapeutics. 66(3). 232–238. 25 indexed citations
19.
Démolis, Pierre, Stephan Chalon, & Jean‐François Giudicelli. (1995). Acetazolamide-Induced Vasodilation in the Carotid Vascular Bed in Healthy Volunteers. Journal of Cardiovascular Pharmacology. 26(5). 841–844. 9 indexed citations
20.
Démolis, Pierre, et al.. (1992). Effects of an angiotensin converting enzyme inhibitor, ramipril, on intracranial circulation in healthy volunteers. off. British Journal of Clinical Pharmacology. 34(3). 224–230. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anil Verma Breakdown of academic impact, for papers by Manuel Román Breakdown of academic impact, for papers by Yvette McNeil Breakdown of academic impact, for papers by Milou‐Daniel Drici Breakdown of academic impact, for papers by A.A. Ajayi Breakdown of academic impact, for papers by Daniel F. Carr Breakdown of academic impact, for papers by Dolores Ochoa Breakdown of academic impact, for papers by Armel Stockis Breakdown of academic impact, for papers by Guillermo Di Girolamo Breakdown of academic impact, for papers by Christabelle J. Darcy
Rankless by CCL
2026